A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection

• Auteurs principaux: Hsuan-Yu Hung (Auteur), Chung-Yu Chen (Auteur), Yi-Hsiang Liao (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background: The direct-acting antiviral (DAA) agents are widely used to treat hepatitis C virus (HCV) genotype (GT) 1 infection, while it may cause severe liver damage. The objectives of the study were to evaluate the incidence of drug-induced liver injury (DILI), sustained virologic response at pos...